Conference abstract · 20 Jun 2021
EditorialPublished 2014
Progress in Making ‘Ras’ as a Target
Subjects
Pharmaceutical SciencesSimilar by topic
Short communication · 29 Jan 2021
The current therapeutic strategies to target mutant RAS driven cancers rely mostly on inhibitors.
Short communication · 29 Jul 2020
Pharmacology Congress 2020- Redox-dependent targeting of mutant RAS driven cancers
Conference abstract · 17 Jul 2020
Redox-dependent targeting of mutant RAS driven cancers
Research article · 2009
Prevention of Human Immunodeficiency Virus Type 1 Transmission by Pharmaceuticals Targeted to Host Proteins Required for Virus Infection? Consideration of Farnesyl Thiosalicylic Acid, a Ras Inhibitor
More from this journal
The newest in Biochemistry & Pharmacology: Open Access.
Perspective · 4 Mar 2025
Targeting Inflammatory Biochemical Pathways for the Development of Anti-Inflammatory Pharmacological Agents
Perspective · 4 Mar 2025
Structural and Functional Insights into Receptor-Ligand Interactions in Drug Design and Pharmacodynamics
Perspective · 4 Mar 2025
Phytochemical Constituents of Medicinal Plants as Potential Anti-Diabetic Therapeutics: Biochemical and Pharmacological Insights
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalBiochemistry & Pharmacology: Open Access
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Sibaprasad Bhattacharyya”

